Resultats de la cerca - Bjoern Rueter

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results per Michael J. Hochman, Amy S. Ruppert, Ying Huang, Alice Mims, Uma Borate, Ronan Swords, Elie Traer, Maria R. Baer, Vu H. Duong, Wendy Stock, Toyosi Odenike, Prapti Patel, Yazan Madanat, Eytan Stein, Michael W. Deininger, Gary Schiller, Daniel A. Pollyea, James M. Foran, Rebecca Olin, Tara Lin, Michael M. Boyiadzis, Shivani Handa, Bjoern Rueter, Theophilus J. Gana, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Amy Burd, Ashley O. Yocum, John C. Byrd, William Blum

Obtenir text complet